Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

The Nobel Prize in medicine was awarded to Victor Ambros, PhD, of the University of Massachusetts, and Gary Ruvkun, PhD, of ...

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

The drug and biotech industry has done well this year, driven by increased mergers and acquisitions (M&A), the launch of ...

Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...

Recent health news covers various topics, including government investments in bird flu vaccines, legal considerations of assisted dying in the UK, regulatory issues at Thermo Fisher, infectious ...

Recordati SpA is shelling out $825 million up front for global rights to Enjaymo (sutimlimab), the only therapy approved for treating the rare disease cold agglutinin disease. In the deal with Sanofi ...

As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...

The state alleges this insulin pricing scheme violates the Texas Deceptive Trade Practices Act, constitutes unjust enrichment ...